Last updated: August 6, 2024
Sponsor: Zentrum für Angst und Depressionsbehandlung Zürich
Overall Status: Active - Recruiting
Phase
N/A
Condition
Depression
Treatment
FaReWell Depression
Clinical Study ID
NCT03983291
Version 1.1
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Mild to moderate unipolar depression
Stable treatment for at least 6 weeks
Exclusion
Exclusion Criteria:
Organic mental disorders
Mental disorders due to psychoactive substance use
Schizophrenia and other psychotic disorders
Previous cosmetic procedures (botulinum toxin, fillers, lifting)
Facial palsy
Facial skin disorders
Study Design
Total Participants: 40
Treatment Group(s): 1
Primary Treatment: FaReWell Depression
Phase:
Study Start date:
June 01, 2019
Estimated Completion Date:
December 01, 2025
Study Description
Connect with a study center
Zentrum für Angst- und Depressionsbehandlung
Zürich, 8008
SwitzerlandActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.